STAAR Surgical Company (STAA) — Financial statements
Income statement, balance sheet, and cash flow for STAAR Surgical Company — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2026 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 239↓23.7% | 314↓2.6% | 322↑13.4% | 284↑23.4% | 230 | |
| Cost of Revenue | 57↓23.3% | 74↑6.5% | 70↑14.4% | 61↑17.7% | 52 | |
| Gross Profit | 182↓23.9% | 240↓5.2% | 253↑13.1% | 223↑25.0% | 179 | |
| Operating Expenses | ||||||
| R&D Expenses | 40↓25.8% | 54↑21.6% | 44↑23.4% | 36↑6.3% | 34 | |
| General & Administrative Expenses | 86↓4.6% | 90↑24.3% | 72↑32.1% | 55↑24.0% | 44 | |
| Selling & Marketing Expenses | 103↓5.3% | 108↑0.5% | 108↑21.4% | 89↑32.0% | 67 | |
| SG&A Expenses | 188↓5.0% | 198↑10.0% | 180↑25.5% | 144↑28.9% | 111 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 228↓9.4% | 252↑12.3% | 225↑25.0% | 180↑23.6% | 145 | |
| Total Costs & Expenses | 285↓12.6% | 327↑10.9% | 294↑22.3% | 241↑22.0% | 197 | |
| Operating Results | ||||||
| Operating Income | -46↓264.3% | -13↓144.9% | 28↓35.9% | 44↑31.4% | 33 | |
| Depreciation & Amortization | 9↑26.7% | 7↑34.5% | 5↑13.6% | 5↑23.8% | 4 | |
| EBITDA | -37↓550.7% | -6↓117.2% | 33↓31.2% | 48↑30.6% | 37 | |
| EBIT | -46↓264.3% | -13↓144.9% | 28↓35.9% | 44↑31.4% | 33 | |
| Interest & Other Income | ||||||
| Net Interest Income | 5↓22.3% | 6↓15.4% | 7↑185.4% | 2↑6542.1% | -0.04 | |
| Interest Income | 5↓22.3% | 6↓15.4% | 7↑185.4% | 2 | — | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.04 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | -36↓1120.4% | 4↓36.4% | 6↑219.9% | 2↑186.0% | -2 | |
| Income Before Tax | -82↓808.8% | -9↓126.9% | 34↓26.0% | 46↑45.5% | 31 | |
| Income Tax Expense | -2↓116.3% | 11↓9.7% | 12↑109.8% | 6↑55.2% | 4 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -80↓298.1% | -20↓194.7% | 21↓46.2% | 40↑44.2% | 28 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -80↓298.1% | -20↓194.7% | 21↓46.2% | 40↑44.2% | 28 | |
| Bottom-Line Net Income | -80↓298.1% | -20↓194.7% | 21↓46.2% | 40↑44.2% | 28 | |
| EPS (Basic) | -1.62↓295.1% | -0.41↓193.2% | 0.44↓47.0% | 0.83↑59.6% | 0.52 | |
| EPS (Diluted) | -1.62↓295.1% | -0.41↓195.3% | 0.43↓46.3% | 0.80↑60.0% | 0.50 | |
| Weighted Average Shares | 50↑0.9% | 49↑1.2% | 49↑1.1% | 48↑1.6% | 47 | |
| Weighted Average Diluted Shares | 50↑0.9% | 49↓0.6% | 49↑0.1% | 49↓0.2% | 49 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.